Details for New Drug Application (NDA): 211884
✉ Email this page to a colleague
The generic ingredient in SUCRALFATE is sucralfate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the sucralfate profile page.
Summary for 211884
Tradename: | SUCRALFATE |
Applicant: | Vistapharm |
Ingredient: | sucralfate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 211884
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUCRALFATE | sucralfate | SUSPENSION;ORAL | 211884 | ANDA | PAI Holdings, LLC dba PAI Pharma | 0121-0974 | 0121-0974-00 | 10 TRAY in 1 TRAY (0121-0974-00) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (0121-0974-10) |
SUCRALFATE | sucralfate | SUSPENSION;ORAL | 211884 | ANDA | PAI Holdings, LLC dba PAI Pharma | 0121-0974 | 0121-0974-40 | 4 TRAY in 1 CASE (0121-0974-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (0121-0974-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 1GM/10ML | ||||
Approval Date: | Mar 15, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription